Statements in which the resource exists.
SubjectPredicateObjectContext
dailymed-drugs:285rdf:typehttp://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:285rdf:typedailymed-instance:drugslld:dailymed
dailymed-drugs:285rdfs:labelHYCAMTIN (Capsule)lld:dailymed
dailymed-drugs:285dailymed-instance:activeIng...dailymed-ingredient:topotec...lld:dailymed
dailymed-drugs:285dailymed-instance:boxedWarn...WARNING: Bone Marrow Suppression: HYCAMTIN should be administered only to patients with baseline neutrophil counts of���1,500 cells/mmand a platelet count���100,000 cells/mm. In order to assess the occurrence of bone marrow suppression, blood cell counts should be monitored.lld:dailymed
dailymed-drugs:285dailymed-instance:activeMoi...dailymed-ingredient:topotec...lld:dailymed
dailymed-drugs:285dailymed-instance:inactiveI...dailymed-ingredient:gelatinlld:dailymed
dailymed-drugs:285dailymed-instance:inactiveI...dailymed-ingredient:titaniu...lld:dailymed
dailymed-drugs:285dailymed-instance:inactiveI...dailymed-ingredient:hydroge...lld:dailymed
dailymed-drugs:285dailymed-instance:inactiveI...dailymed-ingredient:glycery...lld:dailymed
dailymed-drugs:285dailymed-instance:genericMe...topotecan hydrochloridelld:dailymed
dailymed-drugs:285dailymed-instance:fullNameHYCAMTIN (Capsule)lld:dailymed
dailymed-drugs:285dailymed-instance:represent...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:285dailymed-instance:routeOfAd...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:285dailymed-instance:nameHYCAMTINlld:dailymed
http://www4.wiwiss.fu-berli...dailymed-instance:producesD...dailymed-drugs:285lld:dailymed